
|Articles|March 19, 2019
EVERSANA Unveils Global Market Access Research Solution
Advertisement
EVERSANA-independent provider of global services for the life sciences industry-released Global Market Access Insights, a new suite of global market access solutions from Health Strategies Insights for biopharma manufacturers. The suite helps manufacturers understand the latest global trends in access, payment, distribution, and administration.
Global Market Access Insights includes:
- Frameworks and proprietary methods.
- Access to a panel of industry experts.
- Address payer stakeholders’ challenges through Global Access Express, which deploys custom research studies to EU5 stakeholders and returns insights within 10 business days.
- Insights on the impact of Evolution of the Global Biosimilars Market and how these blockbuster therapies are evolving in key geographies, including the U.S.
- U.S. Knowledge for Global Market Access to help inform global market access strategies.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5




